Skip to content
Arrow Dx logo — Arrow Dx is creating precision diagnostics by combining AI a...

Arrow Dx

Arrow Dx is creating precision diagnostics by combining AI and nanotechnology through a versatile, portable technology.

United States Boston, United States 3 employees Biotechnology, Health Care +1

General Information

Company Name Arrow Dx
Location United States Boston, United States
Employees 3
Industries Biotechnology, Health Care, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with Arrow Dx. To contact Arrow Dx, visit arrowdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Arrow Dx compare?

A PDF of Arrow Dx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Arrow Dx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Arrow Dx

Arrow Dx is a biotechnology startup based in the United States, dedicated to revolutionizing precision diagnostics by utilizing a combination of Nanotechnology and Artificial Intelligence (AI). The company's mission is to address the pressing need for early screening of non-alcoholic fatty liver disease (NAFLD) with an affordable, sensitive test that can serve as an alternative to the invasive and late-detection method of liver biopsy. This innovative approach extends beyond NAFLD, as Arrow Dx aims to deploy their versatile, portable technology for various applications, including rapid responses to epidemics/pandemics, early diagnosis of complex non-communicable diseases, and emergency room testing. Their technology also presents a cost-effective solution for smaller healthcare providers, potentially benefiting over 100,000 Physician Office Labs in the U.S., independent physicians, and public health workers. Moreover, the company is actively working to develop a test for COVID-19 and other viruses, with initial efforts focused on quantifying the virus in wastewater to aid public health authorities. These initiatives demonstrate Arrow Dx's commitment to providing accessible, reliable diagnostics to a broad range of healthcare professionals and addressing critical public health challenges. Although specific details regarding the company's founding date and recent investments are not available, Arrow Dx presents a compelling opportunity for potential investors seeking to support advancements in precision diagnostics through the convergence of AI and nanotechnology.

Business keywords: Precision Diagnostics, Nanotechnology, Medical Technology, Point-of-care Testing, Non-alcoholic Fatty Liver Disease (NAFLD), Diagnostic Devices, Public Health, COVID-19 Testing, Virus Detection, Biological Compounds, Chemical Compounds, Material Science, Physical Chemistry

No funding data available for Arrow Dx yet.

Arrow Dx Alternatives & Competitors

View All Alternatives
Arrow Dx vs

Focused on early detection of liver disease

Post-IPO Equity
25 employees
Biotechnology, Health Care
Arrow Dx vs

Transforming Medical Diagnostics

Non Equity Assistance
12 employees
Biotechnology, Health and Wellness
Arrow Dx vs

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care

FAQ About Arrow Dx

Arrow Dx is creating precision diagnostics by combining AI and nanotechnology through a versatile, portable technology.
Arrow Dx is headquartered in Boston, United States.
Arrow Dx operates in Biotechnology, Health Care and Life Sciences. Its work centres on Precision Diagnostics, Nanotechnology, Medical Technology and Point-of-care Testing.
Arrow Dx has approximately 3 employees.
Top alternatives and competitors to Arrow Dx include ENDRA Life Sciences (Nasdaq: NDRA), GRIP Molecular Technologies, Inc, EMPE Diagnostics, Vivosens, HeRui BioMed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arrow Dx and ENDRA Life Sciences (Nasdaq: NDRA) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Arrow Dx, https://www.bouncewatch.com/company/arrow-dx, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout